Our Mission

Established in 2013, the Oklahoma Clinical and Translational Science Institute serves as a catalyst for clinical and translational research that improves health and healthcare for Oklahomans, to provide training and infrastructure to help junior investigators to launch independent research careers, and to expand the opportunities of IDeA states and Oklahoma communities to participate in research that improves the health of our residents. 

Oklahoma Shared Clinical and Translational Resources

OSCTR is Oklahoma's NIH-funded IDeA-CTR that provides resources, information, and training to help individuals or communities involved in performing clinical and translational research in the state

Oklahoma Primary Healthcare Improvement Cooperative

 

OPHIC is the implementation science arm of a statewide network to help improve healthcare delivery assisting primary care practices to adopt evidence-based best practices for the care of their patients.

OCTSI Clinical Research Unit

​​

The OCTSI CRU assists medical providers to identify and conduct clinical research opportunities in Oklahoma.

​

2026 REDCapCon

Calling all REDCap professionals! We're excited to announce 2026 REDCapCon!

REDCapCon, an annual REDCap conference, is a three and a half-day event which offers educational and networking opportunities to REDCap administrators around the world! REDCap administrators perform a variety of functions at their institutions including technical support of the installations, end user training and support, account management, and institutional marketing of REDCap.

Oklahoma Health Services Research Conference Coming This Fall

On behalf of the OCTSI and the Department of Medicine, we are pleased to announce the inaugural Oklahoma Health Services Research Conference! This event will showcase national leaders in health services research from outside institutions and across the University of Oklahoma Health Campus. This event is open to all OU students, residents, fellows, faculty, staff, and trainees from all Colleges!

EVENT DATE: 10/27/26 from 7:30 am to 4:30 pm 

OSCTR Pilot Program 2026

The Oklahoma Clinical and Translational Science Institute (OCTSI) and Oklahoma Shared Clinical and Translational Resources (OSCTR) is soliciting applications for its Clinical and Translational Research Pilot (CTRP) Grants Program.

Purpose

OU Health Campus Celebrates Dr. Stavrakis’ Election to ASCI and His Leadership in Translational Cardiac Research

On Tuesday, March 2, 2026, the American Society of Clinical Investigation (ASCI) elected Stavros Stavrakis, MD, PhD, to their historic ranks. Dr. Stavrakis was one of the earliest graduates of the Master of Science in Clinical Translational Science program offered by the University of Oklahoma Health Campus’s Clinical and Translational Science Institute (OCTSI). ASCI last elected a clinician from Oklahoma in 2003, marking this inclusion as a truly significant moment in the history of Oklahoman healthcare.

Subscribe to News

Recent Publications

Heterogeneous effects of nursing staff wages on turnover: evidence from U.S. nursing homes using an instrumental variable approach

Gerontologist. 2026 Apr 13;66(5):gnag030. doi: 10.1093/geront/gnag030.

ABSTRACT

BACKGROUND AND OBJECTIVES: Turnover among nursing staff (registered nurses, licensed practical nurses, and certified nursing assistants [CNAs]) is a long-standing challenge in nursing homes with significant implications for quality of care. This study aimed to examine the relationship between nursing staff wages and turnover.

Happy Healthy Homes Virtual Intervention Improved Rural Family Child Care Home Provider Mealtimes: Partial and Sustained Effects

J Nutr Educ Behav. 2026 Jan 30:S1499-4046(26)00001-1. doi: 10.1016/j.jneb.2026.01.001. Online ahead of print.

ABSTRACT

OBJECTIVE: Family Child Care homes (FCCH) are home-based child care settings that often care for children in their households, operating with limited resources, and are a common choice for children from low-income families. The purpose of this study was to examine changes in FCCH provider feeding practices after a virtual intervention.

DESIGN: Randomized controlled clinical trial.

SETTING: Rural Oklahoma FCCHs.

Endotoxin Markers Are Elevated in Adolescents With Obesity With and Without Metabolic Dysfunction-Associated Steatotic Liver Disease

Pediatr Obes. 2026 Feb;21(2):e70093. doi: 10.1111/ijpo.70093.

ABSTRACT

BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease in paediatric patients. Adult and murine studies have suggested a role for endotoxin from gram-negative bacteria in the development of MASLD, but there is incomplete and conflicting evidence for its role in adolescents.

Media